文献速递泌尿生殖MRUS

计算机辅助诊断系统联合TRUS-MRI靶向穿刺活检提高前列腺癌检出率

Improvement of prostate cancer detection combining a computer-aided diagnostic system with TRUS-MRI targeted biopsy.
PubMed 文献 · Abdom Radiol (NY) · 2019-01-01

研究纳入167例接受3T多参数MRI的前列腺癌疑似患者,由两位专家放射科医生按PI-RADSv2评估并结合CAD系统分析,当CAD靶点与放射学靶点重叠时在重叠区(即靶中靶)行活检。靶中靶法每针靶向活检核心检出率为81.8%,而单纯基于PI-RADS靶点定义为68.6%。

要点

  • 靶中靶法每针靶向活检核心检出率81.8%,高于单纯PI-RADS靶点定义的68.6%。
  • CAD系统诊断敏感度55.2%、特异度74.1%,AUC为0.63(0.54÷0.71)。
  • 人类阅片者ROC分析AUC为0.71(0.63÷0.79)。

核心结论

  • 结合人类阅片者评估与自动CAD系统分析来定义前列腺活检靶点的新共识方法,可提高TRUS-MRI融合活检的每针活检核心检出率;结果提示CAD系统分析与人类阅片者评估相结合是提高靶向活检效率的有效策略。

研究设计与样本

  • 研究共入组420例患者,因排除标准排除253例,最终167例接受诊断性3T多参数MRI;由两位专家放射科医生采用PI-RADSv2和CAD系统评估,对63例患者共212个靶点行TRUS-MRI融合靶向活检,并将MRI数据定量分析与病理科活检报告比较。

诊断标准与关键数值

  • CAD系统诊断敏感度55.2%、特异度74.1%,AUC=0.63(0.54÷0.71)。
  • 人类阅片者ROC分析AUC为0.71(0.63÷0.79)。
  • 靶中靶法每针靶向活检核心检出率为81.8%,单纯基于PI-RADS靶点定义为68.6%。
  • 靶中靶法较高的每针检出率不受技术缺陷和伪影存在的影响。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To validate a novel consensus method, called target-in-target, combining human analysis of mpMRI with automated CAD system analysis, with the aim to increasing the prostate cancer detection rate of targeted biopsies.

METHODS: A cohort of 420 patients was enrolled and 253 patients were rolled out, due to exclusion criteria. 167 patients, underwent diagnostic 3T MpMRI. Two expert radiologists evaluated the exams adopting PI-RADSv2 and CAD system. When a CAD target overlapped with a radiologic one, we performed the biopsy in the overlapping area which we defined as target-in-target. Targeted TRUS-MRI fusion biopsy was performed in 63 patients with a total of 212 targets. The MRI data of all targets were quantitatively analyzed, and diagnostic findings were compared to pathologist's biopsy reports.

RESULTS: CAD system diagnostic performance exhibited sensitivity and specificity scores of 55.2% and 74.1% [AUC = 0.63 (0.54 ÷ 0.71)] , respectively. Human readers achieved an AUC value, in ROC analysis, of 0.71 (0.63 ÷ 0.79). The target-in-target method provided a detection rate per targeted biopsy core of 81.8 % vs. a detection rate per targeted biopsy core of 68.6 % for pure PI-RADS based on target definitions. The higher per-core detection rate of the target-in-target approach was achieved irrespective of the presence of technical flaws and artifacts.

CONCLUSIONS: A novel consensus method combining human reader evaluation with automated CAD system analysis of mpMRI to define prostate biopsy targets was shown to improve the detection rate per biopsy core of TRUS-MRI fusion biopsies. Results suggest that the combination of CAD system analysis and human reader evaluation is a winning strategy to improve targeted biopsy efficiency.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Campa R, Del Monte M, Barchetti G, et al. Improvement of prostate cancer detection combining a computer-aided diagnostic system with TRUS-MRI targeted biopsy. Abdom Radiol (NY). 2019. PMID: 30054684. doi:10.1007/s00261-018-1712-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。